LATTUADA, Emanuela
 Distribuzione geografica
Continente #
NA - Nord America 1.269
EU - Europa 962
AS - Asia 820
SA - Sud America 151
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.213
Nazione #
US - Stati Uniti d'America 1.248
SG - Singapore 330
CN - Cina 313
GB - Regno Unito 280
BR - Brasile 138
SE - Svezia 110
DE - Germania 97
IE - Irlanda 92
HK - Hong Kong 84
FR - Francia 83
IT - Italia 80
RU - Federazione Russa 78
FI - Finlandia 74
UA - Ucraina 24
VN - Vietnam 23
KR - Corea 19
CZ - Repubblica Ceca 16
CA - Canada 13
TR - Turchia 12
JP - Giappone 11
BE - Belgio 9
AR - Argentina 6
MX - Messico 6
ZA - Sudafrica 6
AT - Austria 5
ID - Indonesia 5
IN - India 5
IQ - Iraq 4
NL - Olanda 3
PK - Pakistan 3
BD - Bangladesh 2
CL - Cile 2
EC - Ecuador 2
ES - Italia 2
IL - Israele 2
LT - Lituania 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CD - Congo 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
KW - Kuwait 1
KZ - Kazakistan 1
MA - Marocco 1
MN - Mongolia 1
NO - Norvegia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 3.213
Città #
Southend 246
Chandler 235
Singapore 173
Jacksonville 152
Woodbridge 127
Dublin 91
Hong Kong 84
Dallas 79
Ann Arbor 70
Ashburn 68
Beijing 59
Houston 36
Lawrence 33
Princeton 33
Jinan 32
Wilmington 29
Munich 27
Shenyang 27
Helsinki 26
New York 25
Nanjing 23
Brno 15
Hebei 15
Turku 13
Nanchang 11
Ningbo 11
Verona 11
San Francisco 10
Santa Clara 10
Seoul 10
Tokyo 10
Boardman 9
Brussels 9
Changsha 9
Los Angeles 9
Tianjin 9
Bologna 8
Haikou 8
Hangzhou 8
Redmond 8
Sindelfingen 8
The Dalles 8
Toronto 8
Buffalo 7
Frankfurt am Main 7
Jiaxing 7
Lanzhou 7
Rio de Janeiro 7
Zhengzhou 7
Clearwater 6
Ho Chi Minh City 6
Milan 6
Norwalk 6
São Paulo 6
Taizhou 6
Brooklyn 5
Dong Ket 5
Pignone 5
Atlanta 4
Belo Horizonte 4
Boston 4
Bursa 4
Council Bluffs 4
Guangzhou 4
Scandiano 4
Taiyuan 4
Vicenza 4
Caxias do Sul 3
Columbus 3
Düsseldorf 3
Fairfield 3
Falls Church 3
Fuzhou 3
Giussano 3
Jakarta 3
Johannesburg 3
London 3
Monterrey 3
Moscow 3
Nuremberg 3
Redondo Beach 3
Redwood City 3
Riva 3
Seattle 3
Barbacena 2
Belém 2
Carapicuíba 2
Chapecó 2
Chennai 2
Chicago 2
Deiva Marina 2
Denver 2
Groningen 2
Guarulhos 2
Hanoi 2
Ipatinga 2
Joinville 2
Lahore 2
Limeira 2
Montréal 2
Totale 2.104
Nome #
Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load 136
Acute mediastinitis: a severe complication of transdermal therapy in a patient with ischaemic heart disease. A case report. 130
Dolutegravir 50 mg thrice weekly plus atazanavir 400 mg daily in a long-term virologically suppressed HIV-infected patient 121
Dolutegravir monotherapy in HIV-1-suppressed patients: A feasible regimen in real life 121
Raltegravir/nevirapine dual therapy at reduced doses as 'maintenance' treatment in virally suppressed HIV-infected patients 115
Pneumatocoele formation during Pneumocystis carinii pneumonia in a man with HIV-1 infection. 114
Histoplasmosis in two human immunodeficiency virus-positive immigrants to Italy: clinical features and management in the highly active antiretroviral therapy era. 113
'High' antiretroviral deintensification strategy and cellular HIV DNA levels 112
No improvement of lipodystrophy syndrome in an HIV-infected patient. 111
Discontinuation of non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy: clinical implications in patients on CD4 T-cell-guided treatment interruption. 107
Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients 107
Recreational substance use and tolerance of efavirenz in HIV-1 infected patients 105
Monoclonal gammopathy in HIV-Infected patients on stable antiretroviral therapy: disappearance or deep reduction? 102
Efavirenz dose reduction is associated with improved lipid profile in HIV-1 infected patients 98
Is there a role for TNF-alpha in HIV1-associated lipodystrophy? 97
Enanthema as the first clinical manifestation of abacavir hypersensitivity reaction: a case report. 97
Raltegravir: is a 400 mg once-daily dose enough? 97
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and treatment-naïve patients with HIV-1 infection: an observational, retrospective, multi-centre study 96
Low plasmatic concentration of intensified antiretroviral therapy in a pregnant woman: a case report 95
Relationship between vertebral fractures, bone mineral density, and osteometabolic profile in HIV and Hepatitis B and C-infected patients treated with ART 94
Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir 93
Short-Cycle Therapy (5 days on/2 days off) with a lamivudine-dolutegravir two-drug regimen in a cohort of virologically suppressed HIV-infected patients 92
Darunavir/ritonavir 600/100 mg once daily: it's time for larger non-inferiority randomized trials 87
mIRTAZAPINE IN AN HIV-INFECTED PATIENT WITH PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 86
No influence of nevirapine on vitamin D deficiency in HIV-infected patients 84
Efficacy and safety of TAM-sparing antiretroviral regimens in naive HIV-positive patients 84
Prevalence and clinical significance of Ureaplasma urealyticum and Mycoplasma hominis in the lower genital tract of HIV-1-infected women. 83
Efavirenz dose reduction in HIV-infected patients: a long-term follow-up 82
Increase in visceral adipose tissue in a woman living with HIV after introduction of integrase strand transfer inhibitor 81
Raltegravir plus lamivudine as 'maintenance therapy' in suppressed HIV-1-infected patients in real-life settings 80
Dolutegravir monotherapy and body weight gain in antiretroviral naïve patients 76
Efficacy of a reduced dose of darunavir/ritonavir in a cohort of antiretroviral-naive and -experienced HIV-infected patients: a medium-term follow-up 74
Prior Mycobacterium avium complex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy 62
Short-cycle therapy in {HIV}-infected adults: rilpivirine combination 4 days on/3 days off therapy 44
Totale 3.276
Categoria #
all - tutte 13.186
article - articoli 13.186
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.372


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021203 0 0 13 32 39 26 7 22 16 13 24 11
2021/2022303 29 107 1 25 2 3 3 19 15 11 16 72
2022/2023620 36 85 50 94 62 154 0 39 77 2 10 11
2023/2024287 16 26 30 21 36 48 2 17 3 14 40 34
2024/2025673 37 41 15 97 38 13 37 18 112 46 62 157
2025/2026346 146 112 88 0 0 0 0 0 0 0 0 0
Totale 3.276